cyclic adp-ribose has been researched along with 4-amylcinnamoylanthranilic acid in 1 studies
| Studies (cyclic adp-ribose) | Trials (cyclic adp-ribose) | Recent Studies (post-2010) (cyclic adp-ribose) | Studies (4-amylcinnamoylanthranilic acid) | Trials (4-amylcinnamoylanthranilic acid) | Recent Studies (post-2010) (4-amylcinnamoylanthranilic acid) |
|---|---|---|---|---|---|
| 758 | 0 | 144 | 33 | 0 | 15 |
| Protein | Taxonomy | cyclic adp-ribose (IC50) | 4-amylcinnamoylanthranilic acid (IC50) |
|---|---|---|---|
| Transient receptor potential cation channel subfamily M member 2 | Homo sapiens (human) | 1.9367 | |
| Transient receptor potential cation channel subfamily M member 8 | Homo sapiens (human) | 3.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inada, H; Togashi, K; Tominaga, M | 1 |
1 other study(ies) available for cyclic adp-ribose and 4-amylcinnamoylanthranilic acid
| Article | Year |
|---|---|
Inhibition of the transient receptor potential cation channel TRPM2 by 2-aminoethoxydiphenyl borate (2-APB).
Topics: Adenosine Diphosphate Ribose; Animals; Antifungal Agents; Boron Compounds; Cell Line; Cinnamates; Cyclic ADP-Ribose; Dose-Response Relationship, Drug; Flufenamic Acid; Hot Temperature; Humans; In Vitro Techniques; Inhibitory Concentration 50; Insulin; Insulin Secretion; Islets of Langerhans; Male; ortho-Aminobenzoates; Patch-Clamp Techniques; Rats; Rats, Wistar; Transfection; TRPM Cation Channels | 2008 |